A multicenter, randomized control study published in the New England Journal of Medicine shows that adding adalimumab to methotrexate therapy for juvenile idiopathic arthritis (JIA)-associated uveitis greatly increases the duration of disease remission.[Read More …] Source: Daily Dose of Eye Care
https://www.lvcenter4sight.com/adding-adalimumab-improves-jia-uveitis-methotrexate-regimen/
Advertisements
